Inception phase University of Rwanda Vaccines incl EU-delegation
: SE-0-SE-6-17121This website displays open data about Swedish aid, which shows when, to whom and for what purpose Swedish aid is paid out, as well as what results it has produced. This page contains information about one of the contributions financed with Swedish aid.
Overview
Inception phase of Rwanda-Sweden for a delegated Team Europe Initiative, MAV+, expected to lead to full contribution with the objective to strengthen capacity for vaccine development and manufacturing in Rwanda; and a planning phase of a research program at University of Rwanda for vaccine uptake and accpetance.
Involved parties
- C01 - Project-type interventions
Strategies governing the contribution
Geographical allocation of the contribution
No countries have been assigned to this contribution.
Development areas for the contribution
No development areas have been assigned to this contribution.
Duration of the contribution
Committed and disbursed amount
Paid per year (net value)
- 2024: SEK 420,000
Sustainable Development Goals
The contributions contribution to the UN's global sustainability goals.
